T1D is characterized by the destruction of beta cells through autoimmune processes, leading to a complete deficiency of insulin, whereas T2D is characterized by insulin resistance, resulting in a relative deficiency of insulin supply (Memon and Abdelalim, 2020; Bourgeois et al., 2021). The gene discussed is INS; the disease is Insulin resistance.